Anti-mouse PD-L1 (B7-H1)-InVivo

製品コード：A2115         Batch: A211527

印刷

Anti-mouse PD-L1 (B7-H1)-InVivo (Clone:10F.9G2) monoclonal antibody reacts with mouse PD-L1 (also known as B7-H1, CD274). The 10F.9G2 antibody has been shown to block the interaction between PD-L1 and PD-1 and between PD-L1 and B7-1 (CD80).

製品説明

Formulation PBS Buffer, PH 7.4
Clone 10F.9G2
Immunogen Mouse CD274
Isotype Rat,IgG2b, κ
Application in vivo PD-L1 blockade,IHC (frozen),FCM
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Shipping Shipped under low temperature conditions
Sterility 0.2 μM filtered
Purity 99%
Protein concentration 5.99 mg/mL
Endotoxin Level ＜1 EU/mg

カスタマーフィードバック

数据来源于[Data independently produced by , ]

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape [ Cancer Commun (Lond), 2024, 10.1002/cac2.12545] PubMed: 38734931
Bioactive nanocomposite hydrogel enhances postoperative immunotherapy and bone reconstruction for osteosarcoma treatment [ Biomaterials, 2024, 312:122714] PubMed: 39079462
TNKS1BP1 facilitates ubiquitination of CNOT4 by TRIM21 to promote hepatocellular carcinoma progression and immune evasion [ Cell Death Dis, 2024, 15(7):511.] PubMed: 39019859
TNKS1BP1 facilitates ubiquitination of CNOT4 by TRIM21 to promote hepatocellular carcinoma progression and immune evasion [ Cell Death Dis, 2024, 15(7):511] PubMed: 39019859
[ Int J Nanomedicine, 2024, ] PubMed: 38348177
Precision USPIO-PEG-SLex Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy Resistance [ Int J Nanomedicine, 2024, 19:1249-1272] PubMed: 38348177
Stabilization of EREG via STT3B-mediated N-glycosylation is critical for PDL1 upregulation and immune evasion in head and neck squamous cell carcinoma [ Int J Oral Sci, 2024, 16(1):47] PubMed: 38945975
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma [ J Immunother Cancer, 2023 , 11(11):e007479.] PubMed: 38030304

人間や獣医の診断であるか治療的な使用のためにでない。